Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis

Csaba Molnár, Sarolta Molnár, Judit Bedekovics, Attila Mokánszki, Ferenc Győry, Endre Nagy, G. Méhes

Research output: Contribution to journalArticle

Abstract

Thyroid cancer (TC) coexisting with Hashimoto’s thyroiditis (HT) presents with several characteristic features including multifocality and lower clinical stages compared to de novo carcinomas but its exact biology is still not understood. We reexamined clinico-pathological and molecular correlations between Hashimoto’s thyroditis and papillary thyroid cancer. A total of 262 patients with TC was evaluated who underwent thyroidectomy at the Surgical Department of the University of Debrecen. Clinical data, histology and molecular data were evaluated. Our cohort included 43 patients (16.4%) with (5 male, 38 female) and 219 (83.6%) patients without coexisting HT (48 male, 171 female). Hashimoto’s thyroiditis related thyroid cancer presented predominantly (93.0% of the cases) with the papillary histological type. Multifocality was observed more frequently with coexisting HT (16/40; 40.0%) compared to cases uninvolved (45/190; 23.7%)(p = 0.034). In contrast, lymphatic metastasis (pN1) with a significantly reduced frequency in patients with HT (4/11; 36.4%) then without HT (34/41 pN1; 82.9%)(p = 0.002). BRAF V600E mutation could be demonstrated at significantly lower rates in cases of PTC + HT (32.1 vs 60.7%, p < 0.005). High incidence, multifocality and papillary morphology strongly support a causal relation between TC and preexisting Hashimoto’s thyroiditis, the latter to be considered as a preneoplastic condition promoting thyroid carcinogenesis.

Original languageEnglish
JournalPathology and Oncology Research
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Hashimoto Disease
Thyroid Neoplasms
Precancerous Conditions
Lymphatic Metastasis
Factor IX
Thyroidectomy
Histology
Thyroid Gland
Carcinogenesis
Carcinoma
Mutation
Incidence

Keywords

  • Carcinoma
  • Clinicopathology
  • Hashimoto thyreoiditis
  • Molecular pathology
  • Thyroid

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis : Clinicopathological and Molecular Characteristics Clue up Pathogenesis. / Molnár, Csaba; Molnár, Sarolta; Bedekovics, Judit; Mokánszki, Attila; Győry, Ferenc; Nagy, Endre; Méhes, G.

In: Pathology and Oncology Research, 01.01.2019.

Research output: Contribution to journalArticle

Molnár, Csaba ; Molnár, Sarolta ; Bedekovics, Judit ; Mokánszki, Attila ; Győry, Ferenc ; Nagy, Endre ; Méhes, G. / Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis : Clinicopathological and Molecular Characteristics Clue up Pathogenesis. In: Pathology and Oncology Research. 2019.
@article{a5c06421414748f8b82e57718de5fb24,
title = "Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis",
abstract = "Thyroid cancer (TC) coexisting with Hashimoto’s thyroiditis (HT) presents with several characteristic features including multifocality and lower clinical stages compared to de novo carcinomas but its exact biology is still not understood. We reexamined clinico-pathological and molecular correlations between Hashimoto’s thyroditis and papillary thyroid cancer. A total of 262 patients with TC was evaluated who underwent thyroidectomy at the Surgical Department of the University of Debrecen. Clinical data, histology and molecular data were evaluated. Our cohort included 43 patients (16.4{\%}) with (5 male, 38 female) and 219 (83.6{\%}) patients without coexisting HT (48 male, 171 female). Hashimoto’s thyroiditis related thyroid cancer presented predominantly (93.0{\%} of the cases) with the papillary histological type. Multifocality was observed more frequently with coexisting HT (16/40; 40.0{\%}) compared to cases uninvolved (45/190; 23.7{\%})(p = 0.034). In contrast, lymphatic metastasis (pN1) with a significantly reduced frequency in patients with HT (4/11; 36.4{\%}) then without HT (34/41 pN1; 82.9{\%})(p = 0.002). BRAF V600E mutation could be demonstrated at significantly lower rates in cases of PTC + HT (32.1 vs 60.7{\%}, p < 0.005). High incidence, multifocality and papillary morphology strongly support a causal relation between TC and preexisting Hashimoto’s thyroiditis, the latter to be considered as a preneoplastic condition promoting thyroid carcinogenesis.",
keywords = "Carcinoma, Clinicopathology, Hashimoto thyreoiditis, Molecular pathology, Thyroid",
author = "Csaba Moln{\'a}r and Sarolta Moln{\'a}r and Judit Bedekovics and Attila Mok{\'a}nszki and Ferenc Győry and Endre Nagy and G. M{\'e}hes",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12253-019-00580-w",
language = "English",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis

T2 - Clinicopathological and Molecular Characteristics Clue up Pathogenesis

AU - Molnár, Csaba

AU - Molnár, Sarolta

AU - Bedekovics, Judit

AU - Mokánszki, Attila

AU - Győry, Ferenc

AU - Nagy, Endre

AU - Méhes, G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Thyroid cancer (TC) coexisting with Hashimoto’s thyroiditis (HT) presents with several characteristic features including multifocality and lower clinical stages compared to de novo carcinomas but its exact biology is still not understood. We reexamined clinico-pathological and molecular correlations between Hashimoto’s thyroditis and papillary thyroid cancer. A total of 262 patients with TC was evaluated who underwent thyroidectomy at the Surgical Department of the University of Debrecen. Clinical data, histology and molecular data were evaluated. Our cohort included 43 patients (16.4%) with (5 male, 38 female) and 219 (83.6%) patients without coexisting HT (48 male, 171 female). Hashimoto’s thyroiditis related thyroid cancer presented predominantly (93.0% of the cases) with the papillary histological type. Multifocality was observed more frequently with coexisting HT (16/40; 40.0%) compared to cases uninvolved (45/190; 23.7%)(p = 0.034). In contrast, lymphatic metastasis (pN1) with a significantly reduced frequency in patients with HT (4/11; 36.4%) then without HT (34/41 pN1; 82.9%)(p = 0.002). BRAF V600E mutation could be demonstrated at significantly lower rates in cases of PTC + HT (32.1 vs 60.7%, p < 0.005). High incidence, multifocality and papillary morphology strongly support a causal relation between TC and preexisting Hashimoto’s thyroiditis, the latter to be considered as a preneoplastic condition promoting thyroid carcinogenesis.

AB - Thyroid cancer (TC) coexisting with Hashimoto’s thyroiditis (HT) presents with several characteristic features including multifocality and lower clinical stages compared to de novo carcinomas but its exact biology is still not understood. We reexamined clinico-pathological and molecular correlations between Hashimoto’s thyroditis and papillary thyroid cancer. A total of 262 patients with TC was evaluated who underwent thyroidectomy at the Surgical Department of the University of Debrecen. Clinical data, histology and molecular data were evaluated. Our cohort included 43 patients (16.4%) with (5 male, 38 female) and 219 (83.6%) patients without coexisting HT (48 male, 171 female). Hashimoto’s thyroiditis related thyroid cancer presented predominantly (93.0% of the cases) with the papillary histological type. Multifocality was observed more frequently with coexisting HT (16/40; 40.0%) compared to cases uninvolved (45/190; 23.7%)(p = 0.034). In contrast, lymphatic metastasis (pN1) with a significantly reduced frequency in patients with HT (4/11; 36.4%) then without HT (34/41 pN1; 82.9%)(p = 0.002). BRAF V600E mutation could be demonstrated at significantly lower rates in cases of PTC + HT (32.1 vs 60.7%, p < 0.005). High incidence, multifocality and papillary morphology strongly support a causal relation between TC and preexisting Hashimoto’s thyroiditis, the latter to be considered as a preneoplastic condition promoting thyroid carcinogenesis.

KW - Carcinoma

KW - Clinicopathology

KW - Hashimoto thyreoiditis

KW - Molecular pathology

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=85060540723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060540723&partnerID=8YFLogxK

U2 - 10.1007/s12253-019-00580-w

DO - 10.1007/s12253-019-00580-w

M3 - Article

AN - SCOPUS:85060540723

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

ER -